SMW Free Realtime Trade Alerts -- Fast Moving Stocks < $15 -- Join Today for FREE!!

Organovo Holdings, Inc.
(NASDAQ : ONVO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Loading ONVO News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
1.62%79.121.1%$779.04m
AMGNAmgen Inc.
0.81%166.791.2%$478.24m
SRPTSarepta Therapeutics, Inc.
0.71%61.4127.0%$477.71m
BIIBBiogen Inc.
2.37%313.031.1%$447.74m
CELGCelgene Corporation
1.69%104.510.9%$402.67m
MDVNMedivation, Inc.
0.05%81.481.9%$381.25m
REGNRegeneron Pharmaceuticals, Inc.
-1.07%402.023.7%$314.38m
CPHDCepheid
-0.08%52.695.5%$220.42m
ALXNAlexion Pharmaceuticals, Inc.
2.07%122.542.2%$181.45m
CLVSClovis Oncology, Inc.
4.07%36.0528.4%$159.66m
ILMNIllumina, Inc.
2.89%181.663.4%$148.67m
VRTXVertex Pharmaceuticals Incorporated
2.60%87.212.3%$139.76m
INCYIncyte Corporation
2.17%94.292.8%$132.54m
TSROTESARO, Inc.
-0.34%100.2417.5%$113.57m
BMRNBioMarin Pharmaceutical Inc.
-0.28%92.524.0%$112.23m

Company Profile

Organovo Holdings, Inc. is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo Holdings was founded on January 30, 2012 and is headquartered in San Diego, CA.